Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangosteen Supplement with Sitagliptin/Metformin in Type 2 Diabetes
NCT07172269Completed
- Start
- Sep 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms). Primary endpoint: Change in Hemoglobin A1c at 12 weeks. Started Sep 2024; status: completed.
Beyond the preview
Go deeper on NCT07172269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172269.